CA2418506A1 - Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases - Google Patents
Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases Download PDFInfo
- Publication number
- CA2418506A1 CA2418506A1 CA002418506A CA2418506A CA2418506A1 CA 2418506 A1 CA2418506 A1 CA 2418506A1 CA 002418506 A CA002418506 A CA 002418506A CA 2418506 A CA2418506 A CA 2418506A CA 2418506 A1 CA2418506 A1 CA 2418506A1
- Authority
- CA
- Canada
- Prior art keywords
- positively influence
- airway diseases
- identifying substances
- chronic inflammatory
- inflammatory conditions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/12—Pulmonary diseases
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pathology (AREA)
- Animal Behavior & Ethology (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Analytical Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
Abstract
The present invention relates to substances which modulate receptors involved in inflammatory processes and whose modulated functions positively influence inflammatory diseases.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0021484.1A GB0021484D0 (en) | 2000-09-01 | 2000-09-01 | Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases |
GB0021484.1 | 2000-09-01 | ||
PCT/EP2001/009727 WO2002018938A1 (en) | 2000-09-01 | 2001-08-23 | Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2418506A1 true CA2418506A1 (en) | 2002-03-07 |
CA2418506C CA2418506C (en) | 2009-04-28 |
Family
ID=9898663
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002418506A Expired - Fee Related CA2418506C (en) | 2000-09-01 | 2001-08-23 | Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1315963A1 (en) |
JP (1) | JP2004507262A (en) |
AU (1) | AU2001282118A1 (en) |
CA (1) | CA2418506C (en) |
GB (1) | GB0021484D0 (en) |
MX (1) | MXPA03001506A (en) |
WO (1) | WO2002018938A1 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1364017A2 (en) * | 2000-08-18 | 2003-11-26 | Novartis AG | Inflammation related g-protein coupled receptor |
WO2003023007A2 (en) | 2001-09-07 | 2003-03-20 | Bristol-Myers Squibb Company | Polynucleotide encoding a novel human g-protein coupled receptor, hgprbmy39 |
US6902902B2 (en) | 2001-11-27 | 2005-06-07 | Arena Pharmaceuticals, Inc. | Human G protein-coupled receptors and modulators thereof for the treatment of metabolic-related disorders |
JP2005536187A (en) * | 2002-04-03 | 2005-12-02 | バイエル・ヘルスケア・アクチェンゲゼルシャフト | Diagnosis and treatment of diseases associated with N-formyl peptide receptor-like 1 (FPRL1) |
US7189524B1 (en) | 2002-11-25 | 2007-03-13 | Amgen, Inc. | Receptor ligands and methods of modulating receptors |
EP1597586A2 (en) * | 2003-02-13 | 2005-11-23 | Bayer HealthCare AG | Diagnostics and therapeutics for diseases associated with hm74 |
EP1603585A2 (en) | 2003-03-14 | 2005-12-14 | Bristol-Myers Squibb Company | Polynucleotide encoding a novel human g-protein coupled receptor variant of hm74, hgprbmy74 |
RU2006133540A (en) * | 2004-02-20 | 2008-03-27 | Авентис Фармасьютикалз Инк. (Us) | FUROSEMIDE MODULATORS NM74 |
RU2006133539A (en) * | 2004-02-20 | 2008-03-27 | Авентис Фармасьютикалз Инк. (Us) | OXIDE DECAGIDRONAFTALINE HM74 MODULATORS |
EP1960792A2 (en) * | 2005-12-07 | 2008-08-27 | Boehringer Ingelheim International Gmbh | Treatment and diagnostics of inflammatory diseases |
JP6151129B2 (en) * | 2013-08-19 | 2017-06-21 | テルモ株式会社 | Fibrotic agent |
JP6210794B2 (en) * | 2013-08-19 | 2017-10-11 | テルモ株式会社 | Fibrotic agent |
AU2018308364C1 (en) | 2017-07-26 | 2023-02-16 | Forty Seven, Inc. | Anti-SIRP-alpha antibodies and related methods |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5648344A (en) * | 1990-07-30 | 1997-07-15 | Glycomed Incorporated | Methods of treating inflammation using selection binding compounds |
ATE197646T1 (en) * | 1990-08-06 | 2000-12-15 | Chiron Corp | METHOD FOR DETECTING CYTOKINE CONVERTASE INHIBITORS |
WO1994025570A1 (en) * | 1993-04-23 | 1994-11-10 | Sloan-Kettering Institute For Cancer Research | Method for screening for targets for anti-inflammatory or anti-allergic agents |
US6160088A (en) * | 1998-07-29 | 2000-12-12 | Sloan-Kettering Institute For Cancer | KDEL receptor inhibitors |
WO2000031261A2 (en) * | 1998-11-25 | 2000-06-02 | Cadus Pharmaceutical Corporation | Methods and compositions for identifying effectors of the formyl peptide receptor like-1 (fprl-1) receptor |
EP1137947B1 (en) * | 1998-12-11 | 2005-10-19 | Children's Hospital Medical Center | Method for determining asthma susceptibility |
EP1364017A2 (en) * | 2000-08-18 | 2003-11-26 | Novartis AG | Inflammation related g-protein coupled receptor |
-
2000
- 2000-09-01 GB GBGB0021484.1A patent/GB0021484D0/en not_active Ceased
-
2001
- 2001-08-23 AU AU2001282118A patent/AU2001282118A1/en not_active Abandoned
- 2001-08-23 JP JP2002523607A patent/JP2004507262A/en active Pending
- 2001-08-23 CA CA002418506A patent/CA2418506C/en not_active Expired - Fee Related
- 2001-08-23 WO PCT/EP2001/009727 patent/WO2002018938A1/en active Application Filing
- 2001-08-23 EP EP01960700A patent/EP1315963A1/en not_active Withdrawn
- 2001-08-23 MX MXPA03001506A patent/MXPA03001506A/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
EP1315963A1 (en) | 2003-06-04 |
CA2418506C (en) | 2009-04-28 |
GB0021484D0 (en) | 2000-10-18 |
MXPA03001506A (en) | 2003-06-09 |
AU2001282118A1 (en) | 2002-03-13 |
JP2004507262A (en) | 2004-03-11 |
WO2002018938A1 (en) | 2002-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003278792A1 (en) | Method and system for improving the liquidity of transactions | |
CA2418506A1 (en) | Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases | |
AU2002210762A1 (en) | System for monitoring publication of content on the internet | |
AU2003250829A1 (en) | System and method for the automatic detection of the expiratory flow limitation | |
DE69719037D1 (en) | SCREEN FOR PARTICLE CONTROL | |
AU2001266072A1 (en) | Flat gasket and method for the production thereof | |
ID27724A (en) | STABILITY OF PARMATION PROVISIONS FROM GAMMA-AMINOBUTIRA ACID DECREASES AND THE PROCESS OF MAKING | |
AU2003265859A1 (en) | Assays and compositions for identifying agents that modulate the activity of deubiquitinating agents | |
DE69838830D1 (en) | Method for reducing the particle size | |
DE69716224D1 (en) | Devices for the production of fine particles | |
AU2001235997A1 (en) | Fluorescent probes for the quantitation of zinc | |
WO2002030353A3 (en) | NF-λB INHIBITORS | |
AU2002315200A1 (en) | Production metering and well testing system background of the invention | |
AU2001294151A1 (en) | System and method for the control of behavioral disorders | |
AU2001293538A1 (en) | Novel protein tyrosine phosphatase inhibitor | |
AU2002242175A1 (en) | Methods for modulating an immune response by modulating the interaction between ctla4 and pp2a | |
ID28010A (en) | CASTING CONTINUOUS FACTORY FOR CASTING CONTINUOUS WAYS FROM THIN SHEETS AND THE METHODS | |
WO2002052270A3 (en) | Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases | |
WO2002052269A3 (en) | Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases | |
AU5855899A (en) | Method for identifying substances for the treatment of c-jun-mediated disorders | |
DE69709576D1 (en) | Device for adjusting the contrast of video images | |
AU2003303347A1 (en) | Method and means for determining specific conditions or changes in the uterine epithelium and in the epithelium of other organs | |
DE50006754D1 (en) | METHOD FOR MAINTAINING THE ENGINE BRAKING EFFECT | |
AU2002237206A1 (en) | Method for the manufacture of gradient gels and method for analysing biomolecules on ultra-long ipg gels | |
AU2002325843A1 (en) | Method for determining the interaction between keratinocytes and neurons |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |